Clinical Trials Directory

Trials / Unknown

UnknownNCT02488577

Outcomes of TAMIS-Total Mesorectal Excision Versus Transanal Loco-regional Excision for T2 Low Rectal Cancer

Outcomes Comparison of TAMIS-TME Versus Transanal Minimally Invasive Locoregional Resection for T2 Low Rectal Cancer: an Open Label Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Osama Mohammad Ali ElDamshety · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Cases with stage T2 N0 low rectal cancer will undergo either Transanal minimally invasive total mesorectal excision or transanal minimally invasive locoregional resection.

Conditions

Interventions

TypeNameDescription
PROCEDURETransanal minimally invasive total mesorectal excision
PROCEDUREtransanal minimally invasive locoregional resection

Timeline

Start date
2015-06-01
Primary completion
2019-06-01
Completion
2019-10-01
First posted
2015-07-02
Last updated
2018-09-12

Source: ClinicalTrials.gov record NCT02488577. Inclusion in this directory is not an endorsement.